A new device for measuring the length of neochordae in mitral mitral valve repair based on perioperative echocardiographic views

Efficacy of a new device for measuring the length of neochordae in mitral mitral valve repair based on perioperative echocardiographic views

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201207218860N4

Enrollment

Registered

2012-08-11

Start date

2012-07-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mitral Valve Disease. Floppy mitral valve syndrome

Interventions

There is just treatment group in this study. Transthoracic echocardiography is performed in all patients. The coordinates of papillary muscle tips and mitral valve leaflets is measured from echocardio

Treatment - Surgery

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria: Patients with Mitral prolaps who undergo mitral valve repair using neochorda.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Mitral Valve prolaps measurment after using neochordae. Timepoint: After operation, 3 months after release. Method of measurement: Transesophageal echocardiography.	—

Secondary

Measure	Time frame
Cardiopulmonary bypass time. Timepoint: During operation. Method of measurement: Timer.;Duration of intubation at ICU. Timepoint: ICU stay. Method of measurement: Timer.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Alireza Alizadeh Ghavidel

Rajaei Heart Center

aghavidel@rhc.ac.ir+98 21 2392 2147

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026